Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Terlipressin for Recidivation Ascites in Cirrhosis
NCT00986817Phase 3Completed
- Sponsor
- Assistance publique - Hôpitaux de Paris
- Start
- Nov 2009
- Primary completion
- Mar 2015
- Modality
- Peptides, Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in ascites comparing Terlipressin + Albumin with Placebo + Albumin (2 arms). Primary endpoint: Mean number of paracentesis between the 2 groups over a 6 months period. Started Nov 2009; status: completed.
02
Drugs
terlipressin
03
Conditions
ascites
Beyond the preview
Go deeper on NCT00986817.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00986817.